Health Belief Model Based Education on Human Papilloma Virus Infection and Vaccination

Not Applicable

Completed

• Conditions: Health Behavior; Human Papilloma Virus
• Interventions: Other: Virtual Education

• Registration Number: NCT05175482
• Lead Sponsor: Marmara University

Brief Summary

To evaluate impact of Health Belief Model Based Education on Human Papilloma Virus Infection and Vaccination among University Students

Detailed Description

In this randomized controlled study, it aims to evaluate impact of Health Belief Model based virtual education on Human Papilloma Virus Infection and Vaccination among University Students.

Study Timeline

• Study First Submitted: 2021-12-12
• Study First Submitted QC: 2021-12-24
• Study Start: 2021-12-30
• Study First Posted: 2022-01-03
• Primary Completion: 2022-06-15
• Study Completion: 2022-09-30
• Status Verified: 2022-10
• Last Update Submitted: 2022-10-06
• Last Update Posted: 2022-10-07

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 127

Inclusion Criteria

• University students aged 18 years or over

Exclusion Criteria

• University students have been received HPV vaccine

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Education received group	Virtual Education	Health belief model based education on HPV infection and vaccination

Primary Outcome Measures

Name	Time	Method
Change from baseline assessment of knowledge level on Human Papilloma Virus (HPV) Infection and Vaccination at first day	baseline and next day after the education (at first day)	The scale consists of 10 items. A higher score represents a higher knowledge level.
Change from baseline score of Human Papilloma Virus (HPV) Infection and Vaccination Health Belief Model Scale at first day	baseline and next day after the education (at first day)	The scale consists of 14 items. The construction of the scale consists of perceived severity (n=4 items), perceived susceptibility (n=2 items), perceived benefit (n=3 items), perceived barriers (n=5 items). A 4-point Likert scale was used to assess each item.

Trial Locations

Locations (1)

Marmara University; 🇹🇷 Istanbul, Turkey